Target Name: ZNF653
NCBI ID: G115950
Review Report on ZNF653 Target / Biomarker Content of Review Report on ZNF653 Target / Biomarker
ZNF653
Other Name(s): Zinc finger protein 653 | zinc finger protein 653 | E430039K05Rik | Zinc finger protein Zip67 | ZIP67 | 67 kDa zinc finger protein | zinc finger protein Zip67 | ZN653_HUMAN

ZNF653: A Potential Drug Target and Biomarker for Neurodegenerative Disorders

Neurodegenerative diseases are a group of disorders that affect the nervous system and can result in progressive cognitive and behavioral decline. These disorders include Alzheimer's disease, Parkinson's disease, Huntington's disease, and other forms of dementia. There is currently no cure for these conditions, and treatments are limited to managing symptoms and improving quality of life. Therefore, the development of new drug targets and biomarkers for neurodegenerative diseases is of great interest. ZNF653 is one of these drug targets and biomarkers that has gained significant attention in recent years.

ZNF653: The Zinc Finger Protein 653

ZNF653 is a zinc finger protein that is expressed in various tissues of the body, including brain, heart, and liver. It is a member of the ZNF family of proteins, which are known for their role in gene regulation and are involved in the development and maintenance of neural stem cells. ZNF653 is unique because it has a unique structure that allows it to interact with other proteins and molecules.

The function of ZNF653 is not well understood, but it is thought to play a role in neural development, cell survival, and neurotransmitter signaling. It is expressed in the brain and is involved in the regulation of neural stem cells, which are critical for the development and maintenance of the nervous system. ZNF653 is also involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time.

ZNF653 as a Drug Target

The development of drug targets for neurodegenerative diseases is an exciting and promising area of research. ZNF653 has the potential to be a drug target because of its involvement in neural development, cell survival, and neurotransmission. There is evidence that ZNF653 interacts with various proteins and molecules, including the protein target GABA-A, which is involved in neurotransmission and is a critical neurotransmitter.

ZNF653 may also interact with the protein target PDGF-BB, which is involved in cell survival and growth. It is also possible that ZNF653 interacts with the protein target NF-kappa-B, which is involved in inflammation and neurodegeneration.

ZNF653 as a Biomarker

In addition to its potential as a drug target, ZNF653 may also be a useful biomarker for neurodegenerative diseases. The development of biomarkers for neurodegenerative diseases is an important area of research because they can help diagnose, monitor, and treat these conditions. ZNF653 may be a useful biomarker for neurodegenerative diseases because of its expression in various tissues of the body and its involvement in neural development and function.

Conclusion

ZNF653 is a protein that has gained significant attention in recent years due to its involvement in neural development, cell survival, and neurotransmission. The potential of ZNF653 as a drug target and biomarker for neurodegenerative diseases is an exciting area of research that may lead to new and effective treatments for these conditions. Further studies are needed to fully understand the role of ZNF653 in neurodegenerative diseases and to develop effective treatments based on this protein.

Protein Name: Zinc Finger Protein 653

Functions: Transcriptional repressor. May repress NR5A1, PPARG, NR1H3, NR4A2, ESR1 and NR3C1 transcriptional activity

The "ZNF653 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF653 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF654 | ZNF655 | ZNF658 | ZNF658B | ZNF66 | ZNF660 | ZNF662 | ZNF663P | ZNF664 | ZNF664-RFLNA | ZNF665 | ZNF667 | ZNF667-AS1 | ZNF668 | ZNF669 | ZNF670 | ZNF670-ZNF695 | ZNF671 | ZNF672 | ZNF674 | ZNF674-AS1 | ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772